News
- Clinical research center conducts clinical trial of Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
- Canadian University carries out resistance training for men living with Obesity
- US company started clinicl trial of Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors
- WHO supports European countries’ response to new virus variant
- Health Canada authorizes Moderna COVID-19 vaccine
- Government of Canada provides $70 million in additional funding to the Red Cross for ongoing COVID-19 response
- Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
- HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
- Results of NIH-sponsored ACTIV-3 trial published
- FDA Warns Companies Illegally Selling CBD Products
- Joint statement calling for urgent country scale-up of access to optimal HIV treatment for infants and children living with HIV
- Progress Update: WHO 1+1 Initiative and Implementation of Youth Declaration to End TB
- European University started clinical trial of Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance
- Medicine company evaluates safety, engraftment and efficacy of VC-01 in patients with T1 Diabetes Mellitus
- US Cancer Center started clinical trial of Exercise Program for the Improvement of Movement and Mobility in Patients With Cancer Undergoing a Blood Stem Cell Transplant
- Cancer Center conducts Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
- FDA Warns Consumers to Avoid Certain Male Enhancement and Weight Loss Products Sold Through Amazon, eBay and Other Retailers Due to Hidden, Potentially Dangerous Drug Ingredients
- WHO and EU join together to support COVID-19 response and systems strengthening in Asia
- New COVID-19 strain: What do we know to date?
- FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer
- WHO promotes distance care for diabetic patients in Czechia during COVID-19
- FDA Approves Prosthetic Implant for Above-the-Knee Amputations
- Turning the tide: Slovenia’s success story of fighting cervical cancer
- EMA recommends first COVID-19 vaccine for authorisation in the EU
- WHO analytical tool helps Ukraine monitor how regions respond to COVID-19
Clinical Research News
Připravované klinické studie
-
Peking University Third HospitalNáborHypertenze | Dyslipidémie | Chronická obstrukční plicní nemoc (CHOPN) | Diabetes mellitus 2. typu (T2DM) | Onemocnění koronárních tepen (CAD) (např. angina pectoris, infarkt myokardu a aterosklerotické onemocnění srdce (ASHD))Čína
-
Tarsus UniversityThe Scientific and Technological Research Council of Turkey; Mersin UniversityZatím nenabíráme
-
Sun Yat-sen UniversityNáborMelanom | Inhibitor imunitního kontrolního boduČína
-
NYU Langone HealthZatím nenabíráme
-
Allied Hospital FaisalabadZatím nenabíráme
-
Guizhou Medical UniversityZatím nenabírámeImunoterapie | Souběžná chemoradioterapie | Rakovina plic (NSCLC)Čína
-
The Fourth Affiliated Hospital of Zhejiang University...Zatím nenabírámeRakovina jater (primární a metastatická)
-
Eli Lilly and CompanyZatím nenabíráme
-
Hospital Authority, Hong KongZatím nenabírámePrenatální diagnostikaHongkong
-
The Fourth Affiliated Hospital of Zhejiang University...Zatím nenabíráme
-
Revision SkincareZatím nenabírámeZtráta vlasů | Ředění vlasů
-
Vrije Universiteit BrusselUniversity Ghent; Universitair Ziekenhuis Brussel (UZB); Kom op tegen Kanker-Fonds...Zatím nenabírámeLife After CancerBelgie
